Cholic acid-modified polyethylenimine: in vitro and in vivo studies

6Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

Abstract

Low-molecular-weight polyethylenimine has lower cytotoxicity than high molecular weight polyethylenimine, but it is not an efficient transfection agent because of limitations of DNA delivery into the cytoplasm. Therefore, in the present study, the hydrophobic modification of low-molecular-weight polyethylenimine (PEI 2 kDa [PEI2]) by cholic acid (ChA) was performed to form PEI2-ChA, and in vitro and in vivo studies were performed. Results indicate that the nanoplexes of PEI2-ChA with gWIZ-GFP have greater transfection efficiency (27%) in NT8e cell lines as evaluated by flow cytometry and also observed by fluorescence imaging. The present study concluded that the transferrin-containing nanoplexes of PEI2-ChA conjugates with plasmid p53 warrant clinical trials in humans after exhaustive animal studies for use as a novel gene delivery system.

Cite

CITATION STYLE

APA

Dube, B., Pandey, A., Joshi, G., Mulherkar, R., & Sawant, K. (2018). Cholic acid-modified polyethylenimine: in vitro and in vivo studies. International Journal of Nanomedicine, 13, 83–85. https://doi.org/10.2147/IJN.S124693

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free